Palvella Therapeutics (PVLA) Other Operating Expenses (2023)
Historic Other Operating Expenses for Palvella Therapeutics (PVLA) over the last 2 years, with Q4 2023 value amounting to -$14.9 million.
- Palvella Therapeutics' Other Operating Expenses changed N/A to -$14.9 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$14.9 million, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of $23.1 million for FY2023, which is N/A changed from last year.
- Per Palvella Therapeutics' latest filing, its Other Operating Expenses stood at -$14.9 million for Q4 2023.
- Palvella Therapeutics' Other Operating Expenses' 5-year high stood at $14.9 million during Q3 2023, with a 5-year trough of -$14.9 million in Q4 2023.